CD33 and breast cancer: Although no difference in the overall frequency of CD11b+CD33+ within HLA-DRneg cells was found (data not shown), a significantly higher percentage of HLA-DRnegCD11b+CD33+ cells also expressing CD15+ was found in the PBMCs of patients with breast cancer compared with controls (Figure 2B).